It’s a sad feeling for all of us.
In the past two years, Indian manufacturing facilities have faced a lot of flak for not conforming to the safety standards set by the drug authorities of importing countries.
This led to mistrust and decreased business for Indian manufacturers, who are otherwise at-par with the world standard (in terms of quality).
Hence manufacturing facilities are taking corrective action, and will be better than most drug manufacturers of the world. It is a steep learning curve, both time-wise and cost-wise.
Source: Guardian LVShare